Suchergebnisse - "Alruwaili, Nabil K"

PubPharm (95)

61

Formulation of amorphous ternary solid dispersions of dapagliflozin using PEG 6000 and Poloxamer 188 : solid-state characterization, ex vivo study, and molecular simulation assessment

enthalten in: Drug development and industrial pharmacy | 2020

von Alruwaili, N. | Zafar, A. | Imam, S. | +8

62

Thymoquinone-Loaded Soy-Phospholipid-Based Phytosomes Exhibit Anticancer Potential against Human Lung Cancer Cells

enthalten in: Pharmaceutics | 2020

von Alhakamy, N. | Badr-Eldin, S. | A Fahmy, U. | +8

RetractionIn: Pharmaceutics. 2024 Jan 23;16(2):. - PMID 38399350

63

Chitosan-Based Microparticles Enhance Ellagic Acid's Colon Targeting and Proapoptotic Activity

enthalten in: Pharmaceutics | 2020

von Alhakamy, N. | Ahmed, O. | Kurakula, M. | +12

RetractionIn: Pharmaceutics. 2024 Jan 30;16(2):. - PMID 38399357

64

Nanotherapeutic systems for delivering cancer vaccines : recent advances

enthalten in: Nanomedicine (London, England) | 2020

von Beg, S. | Alharbi, K. | Alruwaili, N. | +6

65

Nucleic acid-loaded lipid-polymer nanohybrids as novel nanotherapeutics in anticancer therapy

enthalten in: Expert opinion on drug delivery | 2020

von Rahman, M. | Alharbi, K. | Alruwaili, N. | +6

66

Formulation of Chitosan Polymeric Vesicles of Ciprofloxacin for Ocular Delivery : Box-Behnken Optimization, In Vitro Characterization, HET-CAM Irritation, and Antimicrobial Assessment

enthalten in: AAPS PharmSciTech | 2020

von Ameeduzzafar | Alruwaili, N. | Imam, S. | +7

67

Formulation of Chitosan Polymeric Vesicles of Ciprofloxacin for Ocular Delivery: Box-Behnken Optimization, In Vitro Characterization, HET-CAM Irritation, and Antimicrobial Assessment

enthalten in: AAPS PharmSciTech | 2020

von Alruwaili, N. | Imam, S. | Alotaibi, N. | +6

68

Formulation of Chitosan Polymeric Vesicles of Ciprofloxacin for Ocular Delivery: Box-Behnken Optimization, In Vitro Characterization, HET-CAM Irritation, and Antimicrobial Assessment

enthalten in: AAPS PharmSciTech | 2020

von Alruwaili, N. | Imam, S. | Alotaibi, N. | +6

69

Implications of Solid Lipid Nanoparticles of Ganoderic Acid for the Treatment and Management of Hepatocellular Carcinoma

enthalten in: Journal of pharmaceutical innovation | 2020

von Rahman, M. | Beg, S. | Alharbi, K. | +10

70

Implications of Solid Lipid Nanoparticles of Ganoderic Acid for the Treatment and Management of Hepatocellular Carcinoma

enthalten in: Journal of pharmaceutical innovation | 2020

von Rahman, M. | Beg, S. | Alharbi, K. | +10